8-KOther EventsExhibits & Filings

JPMORGAN CHASE & CO 8-K Report, Corporate Update (Jul 5, 2018)

Filed July 5, 2018For Securities:JPMJPM-PCJPM-PDJPM-PKJPM-PLJPM-PMJPM-PJAMJBVYLD

Summary

JPMorgan Chase & Co. (JPM) filed an 8-K on July 5, 2018, to announce a significant adjustment to its outstanding stock warrants. Effective July 6, 2018, the exercise price for these warrants will be reduced to $41.624 per share. This adjustment is made in accordance with the terms of the warrants themselves and is a crucial piece of information for current warrant holders. The filing also reminds investors that the warrants have an upcoming expiration date of October 28, 2018. Warrant holders must exercise their options by Friday, October 26, 2018, to avoid forfeiture. This announcement provides clarity on the terms and impending deadline for those holding JPM warrants.

Key Highlights

  • 1JPM announced a reduction in the exercise price of its outstanding common stock warrants to $41.624 per share.
  • 2The reduced exercise price becomes effective on July 6, 2018.
  • 3This price adjustment is in accordance with the terms of the existing warrant agreements.
  • 4The outstanding warrants are set to expire on October 28, 2018.
  • 5Investors must exercise their warrants by October 26, 2018, the preceding business day, to avoid them becoming void.
  • 6The company attached a press release dated July 5, 2018, as an exhibit detailing this announcement.

Frequently Asked Questions

The main event is the reduction of the exercise price for JPMorgan Chase & Co.'s outstanding common stock warrants to $41.624 per share, effective July 6, 2018.

This filing is most relevant to individuals or entities currently holding outstanding warrants to purchase JPMorgan Chase & Co. common stock.

The warrants expire on Sunday, October 28, 2018. The last business day to exercise them is Friday, October 26, 2018, as any unexercised warrants after this date will become void.

The exercise price was reduced to $41.624 per share in accordance with the specific terms outlined in the outstanding warrant agreements.